Profiles, diagnostic process, and patterns of care of patients with stage III non-small cell lung cancer: A French national study.

Fiche publication

Date publication

janvier 2024

Journal

Respiratory medicine and research

Auteurs

Membres identifiés du Cancéropôle Est :
Pr FALCOZ Pierre-Emmanuel , Dr MARTIN Etienne

Tous les auteurs :
Auliac JB, Greillier L, Martin E, Falcoz PE, Boisselier P, Ano S, Lefrançois M, Cortot A

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/38657298

Résumé

The management of stage III non-small-cell lung cancer (NSCLC) remains heterogeneous and complex, even after the approval of immune checkpoint inhibitors post-chemoradiotherapy (CRT). This observational study from France evaluated real-world practices in managing stage III NSCLC.